TABLE 2.
Susceptibility of 91 H. influenzae isolates from sterile sites in relation to noncapsulated and capsulated strainsa
Antibiotic | Noncapsulated strains (n = 67)
|
Capsulated strains (n = 24)
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
MIC50 | MIC90 | Range | S (%) | I (%) | R (%) | MIC50 | MIC90 | Range | S (%) | I (%) | R (%) | |
Ampicillin | 0.25 | >4 | 0.12->4 | 56 (83.6) | 0 | 11 (16.4) | 0.5 | >4 | 0.25->4 | 13 (54.2) | 0 | 11 (45.8) |
Amoxicillin-clavulanic acid | ≤0.5 | 1 | ≤0.5-1 | 67 (100) | 0 | 0 | ≤0.5 | ≤0.5 | ≤0.5-1 | 24 (100) | 0 | 0 |
Cefuroxime | 0.5 | 1 | 0.25-2 | 67 (100) | 0 | 0 | 0.5 | 1 | 0.25-2 | 24 (100) | 0 | 0 |
Cefotaxime | ≤0.03 | 0.06 | ≤0.03-0.12 | 67 (100) | 0 | 0 | ≤0.03 | 0.06 | ≤0.03-0.06 | 24 (100) | 0 | 0 |
Cefixime | ≤0.25 | ≤0.25 | ≤0.25 | 67 (100) | 0 | 0 | ≤0.25 | ≤0.25 | ≤0.25 | 24 (100) | 0 | 0 |
Cefepime | 0.12 | 0.5 | ≤0.06-0.5 | 67 (100) | 0 | 0 | 0.12 | 0.5 | ≤0.06-0.5 | 24 (100) | 0 | 0 |
Meropenem | ≤0.12 | ≤0.12 | ≤0.12-0.5 | 67 (100) | 0 | 0 | ≤0.12 | ≤0.12 | ≤0.12 | 24 (100) | 0 | 0 |
Clarithromycin | 8 | 16 | 1->16 | 51 (76.1) | 13 (19.4) | 3 (4.5) | 4 | 8 | 2-16 | 22 (91.7) | 2 (8.3) | 0 |
Tetracycline | 0.5 | 0.5 | ≤0.25->4 | 64 (95.5) | 1 (1.5) | 2 (3) | 0.5 | >4 | ≤0.25->4 | 20 (83.3) | 3 (12.5) | 1 (4.2) |
Ciprofloxacin | ≤0.06 | ≤0.06 | ≤0.06 | 67 (100) | 0 | 0 | ≤0.06 | ≤0.06 | ≤0.06 | 24 (100) | 0 | 0 |
Levofloxacin | ≤0.25 | ≤0.25 | ≤0.25 | 67 (100) | 0 | 0 | ≤0.25 | ≤0.25 | ≤0.25 | 24 (100) | 0 | 0 |
Cotrimoxazole | ≤0.5 | >2 | ≤0.5->2 | 43 (64.2) | 6 (9) | 18 (26.9) | >2 | >2 | ≤0.5->2 | 4 (16.7) | 6 (25) | 14 (58.3) |
Chloramphenicol | ≤2 | ≤2 | ≤2->4 | 66 (98.5) | 1 (1.5) | 0 | ≤2 | >4 | ≤2->4 | 19 (79.2) | 3 (12.5) | 2 (8.3) |
Rifampin | ≤0.5 | 1 | ≤0.5-2 | 65 (97) | 2 (3) | 0 | ≤0.5 | ≤0.5 | ≤0.5-1 | 24 (100) | 0 | 0 |
MIC50, MIC90, and range values are expressed in micrograms per milliliter. S, susceptible; I, intermediate; R, resistant.